BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10835998)

  • 1. The management of pain in sickle cell disease.
    Yaster M; Kost-Byerly S; Maxwell LG
    Pediatr Clin North Am; 2000 Jun; 47(3):699-710. PubMed ID: 10835998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of vaso-occlusive pain in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):307-11. PubMed ID: 12679645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the management of the acute painful crisis in sickle cell disease.
    Rees DC; Olujohungbe AD; Parker NE; Stephens AD; Telfer P; Wright J;
    Br J Haematol; 2003 Mar; 120(5):744-52. PubMed ID: 12614204
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and emerging treatments for vaso-occlusive pain in sickle cell disease.
    Dampier C
    Expert Rev Hematol; 2019 Oct; 12(10):857-872. PubMed ID: 31364883
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute pain in children and adults with sickle cell disease: management in the absence of evidence-based guidelines.
    Field JJ; Knight-Perry JE; Debaun MR
    Curr Opin Hematol; 2009 May; 16(3):173-8. PubMed ID: 19295432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell disease -- when opioids and physicians fail.
    Malach S; Levin T; Saravay S; Martin R; Rao S; Horowitz D
    Gen Hosp Psychiatry; 2002; 24(6):442-7. PubMed ID: 12490348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
    Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
    Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant interventions with opioids for vaso-occlusive crisis in sickle cell disease: A mixed treatment network meta-analysis of randomized controlled clinical trials.
    Sridharan K; Sivaramakrishnan G
    J Opioid Manag; 2020; 16(4):267-275. PubMed ID: 32885834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
    Yale SH; Nagib N; Guthrie T
    Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain management in children with sickle cell disease.
    Stinson J; Naser B
    Paediatr Drugs; 2003; 5(4):229-41. PubMed ID: 12662119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A holistic approach to vaso-occlusive pain crisis in children with sickle cell disease.
    Houser B; Plawecki HM; Carr J; Smith MA; Plawecki JA
    J Holist Nurs; 1992 Mar; 10(1):62-75. PubMed ID: 1293205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain management for sickle cell disease.
    Dunlop RJ; Bennett KC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003350. PubMed ID: 16625580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tramadol infusion for the pain management in sickle cell disease: a case report.
    Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
    Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation.
    Admiraal M; van Daalen J; Ritt MWJ; Dekker J; van Tuijn CFJ; Nur E; Hollmann MW; Hermanns H; Hermanides J; Biemond BJ
    Eur J Haematol; 2023 Sep; 111(3):382-390. PubMed ID: 37277324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
    Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
    Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.